Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
The latest update is out from Panbela Therapeutics ( (PBLA) ).
On February 12, 2025, Panbela Therapeutics, Inc. announced a reduction in the annual compensation for their CEO and President, Jennifer K. Simpson, and their VP of Finance and CFO, Susan Horvath. Dr. Simpson’s new annual salary is approximately $30,200, while Ms. Horvath’s is $23,150, reflecting a significant adjustment in executive compensation.
More about Panbela Therapeutics
YTD Price Performance: -24.44%
Average Trading Volume: 18,279
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $1.65M
For a thorough assessment of PBLA stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue